European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) was the target of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totalling 800 shares, a decrease of 52.9% from the August 31st total of 1,700 shares. Based on an average daily volume of 17,100 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

Institutional Inflows and Outflows

An institutional investor recently raised its position in European Biotech Acquisition stock. Cubist Systematic Strategies LLC grew its stake in shares of European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) by 136.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 60,555 shares of the company's stock after purchasing an additional 34,896 shares during the quarter. Cubist Systematic Strategies LLC's holdings in European Biotech Acquisition were worth $593,000 at the end of the most recent quarter.

European Biotech Acquisition Stock Down 1.5 %

Shares of EBAC traded down $0.15 during midday trading on Wednesday, hitting $9.88. 21,111 shares of the company traded hands, compared to its average volume of 29,521. The stock's 50-day moving average is $9.88. European Biotech Acquisition has a one year low of $9.66 and a one year high of $10.50.

European Biotech Acquisition Company Profile

European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.

See Also

• Get a free copy of the StockNews.com research report on European Biotech Acquisition (EBAC)
• Can United Natural Foods Fight Both Inflation and the Fed?
• Mullen Automotive Is Ready To Get In Gear
• Cracker Barrel: A Tasty Treat Or Bad Apple?
• Defensive Stocks For A Volatile Market
• Will UPS Be Next to Deliver a Warning?

Receive News & Ratings for European Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for European Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.